http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08c0e65c88f347f8bffc3f64fd2b9b79
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Migliardi |
| name | Giorgia Migliardi |
| given-name | Giorgia |
| organization-name | IRCC, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy Laboratory of Clinical Oncology, Department of Oncological Sciences, University of Torino Medical School, IRCC, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy Authors' Affiliations: 1Department of Medical Oncology, University of Turin Medical School; 2Unit of Molecular Pharmacology, Department of Oncological Sciences, University of Turin; 3Unit of Pathology, Fondazione del Piemonte per l'Oncologia; and 4Laboratory of Tumor Microenvironment, Fondazione Piemontese per la Ricerca sul Cancro, Institute for Cancer Research and Treatment (IRCC), Candiolo, Turin, Italy Authors' Affiliations: 1Department of Oncology, University of Torino; 2IRCC Institute for Cancer Research and Treatment at Candiolo, Candiolo, Torino; 3FIRC Institute of Molecular Oncology (IFOM); 4Division of Pathology and 5Falck Division of Medical Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy;6Janssen Research and Development, Beerse, Belgium; and 7Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland; Authors' Affiliations: 1Department of Oncology, University of Torino; 2IRCC Institute for Cancer Research and Treatment at Candiolo, Candiolo, Torino; 3FIRC Institute of Molecular Oncology (IFOM); 4Division of Pathology and 5Falck Division of Medical Oncology, Ospedale Niguarda Ca' Granda, Milano, Italy;6Janssen Research and Development, Beerse, Belgium; and 7Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins Kimmel Cancer Center, Baltimore, Maryland Laboratory of Medical Oncology, Institute for Cancer Research and Treatment, Candiolo, Italy Department of Oncology, University of Torino Medical School, 10060 Candiolo, Torino, Italy.; Translational Cancer Medicine, Candiolo Cancer Institute–Fondazione del Piemonte per l’Oncologia (FPO) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 10060 Candiolo, Torino, Italy. 1Department of Oncology, University of Turin Medical School, Turin, Italy.; 2Laboratory of Translational Cancer Medicine, Candiolo Cancer Institute–FPO IRCCS, Turin, Italy. Authors' Affiliations: 1Laboratory of Molecular Pharmacology, 2Laboratory of Oncogenomics, 3Laboratory of Systems Biology, 4Laboratory of Molecular Genetics, 5Division of Surgical Oncology, 6Unit of Pathology, 7Clinical Coordination Unit, and 8Molecular Clinical Oncology, Institute for Cancer Research and Treatment, Torino; Departments of 9Oncological Sciences and 10Biomedical Sciences and Human Oncology, University of Torino Medical School, Torino; 11Department of Surgery, Mauriziano Umberto I Hospital, Torino; 12FIRC Institute of Molecular Oncology, Milano; 13Division of Pathology, 14Falck Division of Medical Oncology, Ospedale Niguarda Ca' Granda, Milano; and 15Southern Europe New Drug Organization Foundation, Milano, Italy; Authors' Affiliations: 1Laboratory of Molecular Pharmacology, 2Laboratory of Oncogenomics, 3Laboratory of Systems Biology, 4Laboratory of Molecular Genetics, 5Division of Surgical Oncology, 6Unit of Pathology, 7Clinical Coordination Unit, and 8Molecular Clinical Oncology, Institute for Cancer Research and Treatment, Torino; Departments of 9Oncological Sciences and 10Biomedical Sciences and Human Oncology, University of Torino Medical School, Torino; 11Department of Surgery, Mauriziano Umberto I Hospital, Torino; 12FIRC Institute of Molecular Oncology, Milano; 13Division of Pathology, 14Falck Division of Medical Oncology, Ospedale Niguarda Ca' Granda, Milano; and 15Southern Europe New Drug Organization Foundation, Milano, Italy Authors' Affiliations: 1Laboratory of Molecular Pharmacology, 2Laboratory of Molecular Genetics, 3Division of Surgical Oncology, 4Unit of Pathology, 5Clinical Coordination Unit, 6Molecular Clinical Oncology, Institute for Cancer Research and Treatment (IRCC); 7Department of Oncological Sciences, University of Torino Medical School, Candiolo; 8Department of Surgery, Mauriziano Umberto I Hospital, Torino; 9Southern Europe New Drug Organization (SENDO) Foundation; and 10FIRC Institute of Molecular Oncology (IFOM), Milano, Italy; Authors' Affiliations: 1Laboratory of Molecular Pharmacology, 2Laboratory of Molecular Genetics, 3Division of Surgical Oncology, 4Unit of Pathology, 5Clinical Coordination Unit, 6Molecular Clinical Oncology, Institute for Cancer Research and Treatment (IRCC); 7Department of Oncological Sciences, University of Torino Medical School, Candiolo; 8Department of Surgery, Mauriziano Umberto I Hospital, Torino; 9Southern Europe New Drug Organization (SENDO) Foundation; and 10FIRC Institute of Molecular Oncology (IFOM), Milano, Italy 2Department of Oncology, University of Torino Medical School, Torino, Italy.; 3Translational Cancer Medicine, Candiolo Cancer Institute – FPO IRCCS, Torino, Italy. Department of Oncological Sciences, Laboratory of Clinical Oncology, University of Torino Medical School, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy; and Department of Oncology University of Torino, School of Medicine Torino Italy; Laboratory of Molecular Pharmacology Institute for Cancer Research at Candiolo Torino Italy 2Department of Oncology, University of Torino, Candiolo, Italy.; 3Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. Department of Genetics, Biology, and Biochemistry, and |
Incoming Links
Total number of triples: 44.